Synthesis and anti-HIV activity of oligoribonucleotides and their phosphorothioate analogs. 1992

S Agrawal, and J Y Tang, and D Sun, and P S Sarin, and P C Zamecnik
Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts 01545.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009691 Nucleic Acid Denaturation Disruption of the secondary structure of nucleic acids by heat, extreme pH or chemical treatment. Double strand DNA is "melted" by dissociation of the non-covalent hydrogen bonds and hydrophobic interactions. Denatured DNA appears to be a single-stranded flexible structure. The effects of denaturation on RNA are similar though less pronounced and largely reversible. DNA Denaturation,DNA Melting,RNA Denaturation,Acid Denaturation, Nucleic,Denaturation, DNA,Denaturation, Nucleic Acid,Denaturation, RNA,Nucleic Acid Denaturations
D009692 Nucleic Acid Heteroduplexes Double-stranded nucleic acid molecules (DNA-DNA or DNA-RNA) which contain regions of nucleotide mismatches (non-complementary). In vivo, these heteroduplexes can result from mutation or genetic recombination; in vitro, they are formed by nucleic acid hybridization. Electron microscopic analysis of the resulting heteroduplexes facilitates the mapping of regions of base sequence homology of nucleic acids. Heteroduplexes, Nucleic Acid,Heteroduplex DNA,Acid Heteroduplexes, Nucleic,DNA, Heteroduplex
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D009843 Oligoribonucleotides A group of ribonucleotides (up to 12) in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012330 RNA, Double-Stranded RNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms. Double-Stranded RNA,Double Stranded RNA,RNA, Double Stranded
D013873 Thionucleotides Nucleotides in which the base moiety is substituted with one or more sulfur atoms.
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

S Agrawal, and J Y Tang, and D Sun, and P S Sarin, and P C Zamecnik
November 1994, Journal of medicinal chemistry,
S Agrawal, and J Y Tang, and D Sun, and P S Sarin, and P C Zamecnik
January 1991, Nucleic acids symposium series,
S Agrawal, and J Y Tang, and D Sun, and P S Sarin, and P C Zamecnik
June 2011, Acta pharmaceutica (Zagreb, Croatia),
S Agrawal, and J Y Tang, and D Sun, and P S Sarin, and P C Zamecnik
April 2009, Organic & biomolecular chemistry,
S Agrawal, and J Y Tang, and D Sun, and P S Sarin, and P C Zamecnik
January 1991, Nucleic acids symposium series,
S Agrawal, and J Y Tang, and D Sun, and P S Sarin, and P C Zamecnik
June 2010, Letters in drug design & discovery,
S Agrawal, and J Y Tang, and D Sun, and P S Sarin, and P C Zamecnik
September 2017, European journal of medicinal chemistry,
S Agrawal, and J Y Tang, and D Sun, and P S Sarin, and P C Zamecnik
January 1989, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie,
S Agrawal, and J Y Tang, and D Sun, and P S Sarin, and P C Zamecnik
November 2008, Bioscience, biotechnology, and biochemistry,
Copied contents to your clipboard!